Eos Energy Enterprises, Inc. Announces Proposed Offering of Common Stock GlobeNewswire May 29, 2025 EDISON, N.J., May 29, 2025 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”) today announced that it has commenced a $75,000,000 common stock offering (the “Offering”). The Offering is being made pursuant to the Securities Act […]
(NasdaqGM:KROS), Discontinues Development of Cibotercept in PAH Announces Corporate Restructuring to Align Operations with Ongoing Strategic Priorities LEXINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”, the “Company” or “we”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders
(TSX:AGI),(NYSE:AGI), All amounts are in United States dollars, unless otherwise stated. TORONTO, May 29, 2025 (GLOBE NEWSWIRE) — Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today announced that the Company's Board of Directors has declared a quarterly dividend of US$0.025 per common share. The Company has paid dividends for 16 consecutive years, including
(NYSE:BBWI), First quarter net sales up 3% to $1.4 billion, at the high end of the guidance range, and earnings per diluted share up 29% to $0.49, exceeding the high end of the guidance range Net sales performance driven by compelling innovation Company maintains 2025 net sales guidance of 1% to 3% growth and earnings
Keros Therapeutics Announces TROPOS Topline Data and Corporate Restructuring GlobeNewswire May 29, 2025 Discontinues Development of Cibotercept in PAH Announces Corporate Restructuring to Align Operations with Ongoing Strategic Priorities LEXINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”, the “Company” or “we”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and
Alamos Gold Declares Quarterly Dividend GlobeNewswire May 29, 2025 All amounts are in United States dollars, unless otherwise stated. TORONTO, May 29, 2025 (GLOBE NEWSWIRE) — Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today announced that the Company's Board of Directors has declared a quarterly dividend of US$0.025 per common share. The Company
Bath & Body Works Reports 2025 First Quarter Results and Maintains Fiscal Year 2025 Guidance GlobeNewswire May 29, 2025 First quarter net sales up 3% to $1.4 billion, at the high end of the guidance range, and earnings per diluted share up 29% to $0.49, exceeding the high end of the guidance range Net sales
(NYSE:KIM), JERICHO, N.Y., May 29, 2025 (GLOBE NEWSWIRE) — Kimco Realty(R) (NYSE: KIM) announced today that members of its management team will present at the Nareit REITweek Investor Conference on Wednesday, June 4, 2025. The webcast information is as follows: When: Wednesday, June 4, 2025 from 9:30 AM – 10:00 AM, ET Live Webcast: Kimco
Kimco Realty(R) Management to Present at Nareit's REITweek: 2025 Investor Conference GlobeNewswire May 29, 2025 JERICHO, N.Y., May 29, 2025 (GLOBE NEWSWIRE) — Kimco Realty(R) (NYSE: KIM) announced today that members of its management team will present at the Nareit REITweek Investor Conference on Wednesday, June 4, 2025. The webcast information is as follows: When:
In 2025, A-share tech-focusedETFs have continued to attract significant investor interests – the top five industry/thematic ETFs by net inflows, as of May 21, were all technology-related, collectively drawing in US$ 7.87 billion, including the E Fund CSI Artificial Intelligence ETF (159819), which saw a net inflow of US$ 1.17 billion. Meanwhile, leading asset managers